Smith JA, Kitt MM, Morice AH, et al. MK-7264, a P2X3 Receptor Antagonist, Reduces Cough Frequency in Patients with Refractory Chronic Cough: Results from a Randomized, Controlled, Phase 2b Clinical Trial. ATS 2017, A7608.
Beloop COPD-exacerbatie in thuissituatie volgen door hoestgeluiden op te nemen
apr 2017 | COPD